
Sign up to save your podcasts
Or


We examine the online dating space and its market share leader, Match Group.
The downturn in oil has forced companies to become even more efficient - and that means they require a lower oil price to make profits.
We compare Biogen's and Celgene's current valuations and consider what might be in store for Gilead Sciences now that its new hepatitis C drug is approved.
We talk value investing in tech to follow up our P/E episode on growth investing. Analyst John Rotonti explains some key metrics he looks at and discusses a few companies he really likes in the tech space.
Volkswagen’s price tag to settle its emissions cheating scandal are now over $15 billion, but is it possible that the worst is behind the German auto maker?
From the publisher's feed

3,155 Listeners

806 Listeners

933 Listeners

1,604 Listeners